DK1218382T3 - Bicykliske imidazo-3-ylaminderivater - Google Patents
Bicykliske imidazo-3-ylaminderivaterInfo
- Publication number
- DK1218382T3 DK1218382T3 DK00967692T DK00967692T DK1218382T3 DK 1218382 T3 DK1218382 T3 DK 1218382T3 DK 00967692 T DK00967692 T DK 00967692T DK 00967692 T DK00967692 T DK 00967692T DK 1218382 T3 DK1218382 T3 DK 1218382T3
- Authority
- DK
- Denmark
- Prior art keywords
- bicyclic imidazo
- ylamine derivatives
- ylamine
- derivatives
- imidazo
- Prior art date
Links
- 125000002619 bicyclic group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19948434A DE19948434A1 (de) | 1999-10-08 | 1999-10-08 | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
DE1999148438 DE19948438B4 (de) | 1999-10-08 | 1999-10-08 | Bicyclische Imidazo-3-aminderivate |
PCT/EP2000/009096 WO2001027111A2 (fr) | 1999-10-08 | 2000-09-18 | Derives d'imidazo-3-yl-amine bicycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1218382T3 true DK1218382T3 (da) | 2004-03-22 |
Family
ID=26055218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00967692T DK1218382T3 (da) | 1999-10-08 | 2000-09-18 | Bicykliske imidazo-3-ylaminderivater |
Country Status (26)
Country | Link |
---|---|
US (1) | US6638933B2 (fr) |
EP (1) | EP1218382B1 (fr) |
JP (1) | JP2003511451A (fr) |
KR (1) | KR100756592B1 (fr) |
CN (1) | CN1257169C (fr) |
AR (1) | AR025962A1 (fr) |
AT (1) | ATE258554T1 (fr) |
AU (1) | AU779197B2 (fr) |
BR (1) | BR0014818A (fr) |
CA (1) | CA2382919C (fr) |
CO (1) | CO5251378A1 (fr) |
CZ (1) | CZ20021210A3 (fr) |
DE (1) | DE50005155D1 (fr) |
DK (1) | DK1218382T3 (fr) |
ES (1) | ES2213611T3 (fr) |
HK (1) | HK1047747B (fr) |
HU (1) | HUP0203052A3 (fr) |
NO (1) | NO322754B1 (fr) |
NZ (2) | NZ518439A (fr) |
PE (1) | PE20010634A1 (fr) |
PL (1) | PL355206A1 (fr) |
PT (1) | PT1218382E (fr) |
RU (1) | RU2264402C2 (fr) |
SK (1) | SK286788B6 (fr) |
UY (1) | UY26372A1 (fr) |
WO (1) | WO2001027111A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
DE10043845A1 (de) * | 2000-09-06 | 2002-03-14 | Gruenenthal Gmbh | Verfahren zur Messung der Aktivität der NO-Synthase |
EP1854798A3 (fr) | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire |
WO2002048146A2 (fr) * | 2000-12-13 | 2002-06-20 | Basf Aktiengesellschaft | Utilisation d'imidazoazines substituees, nouvelles imidazoazines, procede permettant de les produire et agents les contenant |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
DE102004021716A1 (de) * | 2004-04-30 | 2005-12-01 | Grünenthal GmbH | Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen |
CA2570073A1 (fr) * | 2004-06-09 | 2005-12-22 | Oncalis Ag | Inhibiteurs de proteine kinase |
US7923041B2 (en) * | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
KR100968989B1 (ko) * | 2005-03-23 | 2010-07-09 | 에프. 호프만-라 로슈 아게 | mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘 유도체 |
CA2609299A1 (fr) * | 2005-05-20 | 2006-11-23 | Array Biopharma Inc. | Composes inhibiteurs raf et procedes d'utilisation de ceux-ci |
EP1901748B1 (fr) * | 2005-06-09 | 2010-09-08 | Oncalis AG | Inhibiteurs d'angiogenese |
CA2620223A1 (fr) | 2005-09-02 | 2007-03-08 | Abbott Laboratories | Nouveaux heterocycles a base imidazo |
EP1845098A1 (fr) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, leur procédés de préparation et leur utilisation comme ligands du recepteur GABA |
EA200870592A1 (ru) * | 2006-05-31 | 2009-08-28 | Галапагос Н.В. | Триазолопиразиновые соединения, пригодные для лечения дегенеративных и воспалительных заболеваний |
US20100173930A1 (en) * | 2006-08-01 | 2010-07-08 | Alex Muci | Certain Chemical Entities, Compositions and Methods |
US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
ES2558517T3 (es) * | 2006-08-02 | 2016-02-04 | Cytokinetics, Inc. | Ciertas entidades químicas, composiciones y métodos que comprenden imidazopirimidinas |
US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
EP1974729A1 (fr) * | 2007-03-28 | 2008-10-01 | Santhera Pharmaceuticals (Schweiz) AG | Dérivés d'imidazopyridine substitués en tant qu'antagonistes du récepteur de la mélanocortine- 4 |
US7851484B2 (en) * | 2007-03-30 | 2010-12-14 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
GB0708188D0 (en) * | 2007-04-27 | 2007-06-06 | Merck Sharp & Dohme | Therapeutic compounds |
PT2266990E (pt) * | 2008-04-15 | 2012-12-27 | Eisai R&D Man Co Ltd | Composto de 3-fenilpirazolo[5,1-b]tiazole |
CA2730280A1 (fr) * | 2008-07-10 | 2010-01-14 | Southern Research Institute | Composes de 5-quinolinone et d'imidazopyridine et leur utilisation |
WO2010032195A1 (fr) | 2008-09-16 | 2010-03-25 | Csir | Imidazopyridines et imidazopyrimidines utilisés comme inhibiteurs de la transcriptase inverse du vih-1 |
TWI573874B (zh) | 2008-12-05 | 2017-03-11 | 武田疫苗股份有限公司 | 用於誘導病毒生長之組成物、方法及用途 |
AR078521A1 (es) * | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
SG10201605707UA (en) | 2011-07-13 | 2016-09-29 | Cytokinetics Inc | Combination als therapy |
RU2015118985A (ru) | 2012-11-14 | 2017-01-10 | Ф. Хоффманн-Ля Рош Аг | Производные имидазопиридина |
BR112015020998B1 (pt) * | 2013-03-14 | 2022-10-18 | Galapagos Nv | Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios |
WO2017160922A1 (fr) | 2016-03-16 | 2017-09-21 | Kalyra Pharmaceuticals, Inc. | Composés analgésiques |
WO2018200988A1 (fr) | 2017-04-28 | 2018-11-01 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de trim33 et méthodes d'utilisation |
US11530209B2 (en) | 2017-10-04 | 2022-12-20 | Dana-Farber Cancer Institute, Inc. | Small molecule inhibition of transcription factor SALL4 and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0068378B1 (fr) | 1981-06-26 | 1986-03-05 | Schering Corporation | Imidazo(1,2-a)pyridines et pyrazines, procédés pour leur préparation et composés pharmaceutiques les contenant |
NZ221996A (en) * | 1986-10-07 | 1989-08-29 | Yamanouchi Pharma Co Ltd | Imidazo-pyridine derivatives and pharmaceutical compositions |
TW274551B (fr) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
DE4327027A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
KR19990007836A (ko) * | 1995-04-21 | 1999-01-25 | 다나까 테츠오 | 융합된 이미다조[1, 2-a]피리딘 |
US6552037B2 (en) * | 2000-06-30 | 2003-04-22 | Neurogen Corporation | 2-Substituted imidazo[1,2-A]pyridine derivatives |
-
2000
- 2000-09-18 PT PT00967692T patent/PT1218382E/pt unknown
- 2000-09-18 BR BR0014818-0A patent/BR0014818A/pt not_active Application Discontinuation
- 2000-09-18 CA CA002382919A patent/CA2382919C/fr not_active Expired - Fee Related
- 2000-09-18 RU RU2002110102/04A patent/RU2264402C2/ru not_active IP Right Cessation
- 2000-09-18 JP JP2001530329A patent/JP2003511451A/ja not_active Withdrawn
- 2000-09-18 NZ NZ518439A patent/NZ518439A/en unknown
- 2000-09-18 WO PCT/EP2000/009096 patent/WO2001027111A2/fr active IP Right Grant
- 2000-09-18 CN CNB008159866A patent/CN1257169C/zh not_active Expired - Fee Related
- 2000-09-18 CZ CZ20021210A patent/CZ20021210A3/cs unknown
- 2000-09-18 SK SK436-2002A patent/SK286788B6/sk not_active IP Right Cessation
- 2000-09-18 HU HU0203052A patent/HUP0203052A3/hu unknown
- 2000-09-18 DK DK00967692T patent/DK1218382T3/da active
- 2000-09-18 AT AT00967692T patent/ATE258554T1/de active
- 2000-09-18 KR KR1020027004516A patent/KR100756592B1/ko not_active IP Right Cessation
- 2000-09-18 PL PL00355206A patent/PL355206A1/xx not_active IP Right Cessation
- 2000-09-18 EP EP00967692A patent/EP1218382B1/fr not_active Expired - Lifetime
- 2000-09-18 NZ NZ518390A patent/NZ518390A/en unknown
- 2000-09-18 AU AU77771/00A patent/AU779197B2/en not_active Ceased
- 2000-09-18 ES ES00967692T patent/ES2213611T3/es not_active Expired - Lifetime
- 2000-09-18 DE DE50005155T patent/DE50005155D1/de not_active Expired - Lifetime
- 2000-10-05 AR ARP000105254A patent/AR025962A1/es unknown
- 2000-10-05 UY UY26372A patent/UY26372A1/es not_active Application Discontinuation
- 2000-10-05 CO CO00075814A patent/CO5251378A1/es not_active Application Discontinuation
- 2000-10-06 PE PE2000001064A patent/PE20010634A1/es not_active Application Discontinuation
-
2002
- 2002-04-03 NO NO20021565A patent/NO322754B1/no not_active IP Right Cessation
- 2002-04-08 US US10/117,333 patent/US6638933B2/en not_active Expired - Fee Related
- 2002-12-28 HK HK02109382.5A patent/HK1047747B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1218382T3 (da) | Bicykliske imidazo-3-ylaminderivater | |
NO20000885L (no) | 4-Fenyl-pyridin-derivater | |
NO20021077D0 (no) | Amino-triazolopyridin-derivater | |
ATE263748T1 (de) | Admantan-derivate | |
DE50010060D1 (de) | Thiazolylamid-derivate | |
DE50015443D1 (de) | Bicyclische imidazo-5-yl-aminderivate | |
IS6128A (is) | 13-Metýl-erýþrómýsín afleiður | |
DK1187814T3 (da) | 5-phenyl-pyrimidinderivater | |
NO20021803D0 (no) | Isoksazolkarboksamid-derivater | |
ATE257148T1 (de) | Propargyletherderivate | |
PT1154988E (pt) | Derivados de mevinolina | |
ATE374747T1 (de) | Monofluoralkylderivate | |
PT1187815E (pt) | Derivados de 4-fenil-pirimidina | |
DE60006703D1 (de) | 4-hydroxybiphenylhydrazid-derivate | |
ATE293592T1 (de) | Resorcinderivate | |
PT1088818E (pt) | Derivados de quinolin-4-ilo | |
PT1194401E (pt) | Derivados de diacil-hidrazina | |
NO20020212L (no) | 3-amino-2-benzyl-1-fenyl-propanderivater | |
DE60025348D1 (de) | Ethansulfonyl-piperidin-derivate | |
DE60001736T2 (de) | 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate | |
DE59909774D1 (de) | 1-cycloalkylpyrazolyl-benzoyl-derivate |